Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;52(2):732-4.
doi: 10.1128/AAC.01012-07. Epub 2007 Nov 26.

In vitro antifungal susceptibilities of five species of sporothrix

Affiliations

In vitro antifungal susceptibilities of five species of sporothrix

Rita Marimon et al. Antimicrob Agents Chemother. 2008 Feb.

Abstract

Ninety-two isolates belonging to five species of the Sporothrix schenckii complex were tested in vitro against 12 antifungal agents, using a reference microdilution method. There were significant differences among the species; Sporothrix brasiliensis was the species that showed the best response to antifungals, and S. mexicana had the worst response. In general, terbinafine was the most active drug, followed by ketoconazole and posaconazole.

PubMed Disclaimer

References

    1. Conti Díaz, I. A., E. Civila, and E. Gezuele. 1992. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 35:153-156. - PubMed
    1. De Araujo, T., A. C. Marques, and F. Kerdel. 2001. Sporotrichosis. Int. J. Dermatol. 40:737-742. - PubMed
    1. Gilgado, F., J. Cano, J. Gené, and J. Guarro. 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942. - PMC - PubMed
    1. Gilgado, F., C. Serena, J. Cano, J. Gené, and J. Guarro. 2006. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob. Agents Chemother. 50:4211-4213. - PMC - PubMed
    1. Hay, R. J. 1999. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br. J. Dermatol. 141(Suppl. 56):36-40. - PubMed

Publication types

Substances